Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.
Press releases published on April 28, 2025
CD Bioparticles Announces Custom Synthesis Service for Magnetic Sodium Alginate Hydrogel Particles
EIN Presswire
·
April 28, 2025
CD Bioparticles announces new service for custom synthesis and drug encapsulation of Magnetic Sodium Alginate Hydrogel Particles. NEW YORK, NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- With years of experience in the pharmaceutical and life …
Creative Diagnostics Launches Monkeypox Virus Neutralizing Antibody Test Services to Aid in Immune Response Assessment
EIN Presswire
·
April 28, 2025
Creative Diagnostics has announced Monkeypox Virus Neutralizing Antibody Test services for monkeypox research. NEW YORK, NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- As an expert in providing solutions to assist virology and microbiology …
Creative Diagnostics Introduces Advanced tRNA Modification Detection Solutions to Support Genetic Research
EIN Presswire
·
April 28, 2025
Creative Diagnostics has announced its highly validated antibodies for tRNA Modification Detection. NEW YORK, NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and …
DevLand Launches Innovative AI EdTech Platform to Revolutionize Education
EIN Presswire
·
April 28, 2025
Play different LAS VEGAS, NV, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- DevLand, acclaimed as a "bold new EdTech startup," officially launched DevLand Arcade this month, revolutionizing the integration of gaming and education. Founded by tech …
AON Neurodiagnostics, Inc. Achieves 98.9% Growth in 2024 and Record-Breaking Q1 2025 Results
EIN Presswire
·
April 28, 2025
Expansion of Advanced EEG Services Drives Clinical Integration and Sustained Growth in Neurological Patient Care DALLAS, TX, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- AON Neurodiagnostics, Inc., a leader in at-home ambulatory video EEG …
Telix's Illuccix PSMA-PET Imaging Agent Approved in France
GlobeNewswire
·
April 28, 2025
MELBOURNE, Australia, April 29, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET1 imaging agent, Illuccix® (kit for the preparation of gallium-68 gozetotide …
IntegrateRNA offers improved protein engineering capabilities through their sophisticated ncAA-tRNA modification system
EIN Presswire
·
April 28, 2025
NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- The Creative Biogene division IntegrateRNA launched a novel platform that enables post-translational protein modification through the use of non-canonical amino acids and engineered transfer RNA. …
Amplify Energy Schedules First Quarter 2025 Earnings Release and Conference Call
GlobeNewswire
·
April 28, 2025
HOUSTON, April 28, 2025 (GLOBE NEWSWIRE) -- Amplify Energy Corp. (“Amplify” or the “Company”) (NYSE: AMPY) announced today that it will report first quarter 2025 financial and operating results after the U.S. financial markets close on May 12, 2025. …
Bel Fuse Inc. Announces Regular Quarterly Cash Dividend on its Class A and Class B Shares
GlobeNewswire
·
April 28, 2025
WEST ORANGE, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- BEL FUSE INC. (NASDAQ:BELFA) and (NASDAQ:BELFB) today announced that its Board of Directors has declared regular quarterly cash dividends of $0.06 per share on the Company's Class A common shares and $0 …
Significant Paper Published in JAMA on the Effect of Transcranial Pulsed Current Stimulation
EIN Presswire
·
April 28, 2025
SINGAPORE, April 28, 2025 /EINPresswire.com/ -- Singapore-based AscenZion Neuromodulation Co announced the publication of a significant paper on the ‘Effect of transcranial pulsed current stimulation on social functioning in children with autism’ in JAMA …
Supramolecular Bakuchiol in Ionic Liquid Boosts Anti-Aging Efficacy with Less Irritation
EIN Presswire
·
April 28, 2025
FAYETTEVILLE, GA, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- A groundbreaking study published in Supramolecular Materials introduces a novel supramolecular solution of bakuchiol, a plant-derived retinol alternative, using an ionic liquid (IL) …
CVR Partners Reports First Quarter 2025 Results
GlobeNewswire
·
April 28, 2025
First quarter net income of $27 million, or $2.56 per common unit; EBITDA of $53 million Announced cash distribution of $2.26 per common unit SUGAR LAND, Texas, April 28, 2025 (GLOBE NEWSWIRE) -- CVR Partners, LP (NYSE: UAN, “CVR Partners” or the “ …
ElevateBio Announces Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
GlobeNewswire
·
April 28, 2025
– Oral and poster presentations will highlight advancements from ElevateBio’s two business units: Life Edit, its gene editing and R…
IgA Nephropathy Foundation Celebrates 21 Years of Advocacy, Awareness, and Progress
EIN Presswire
·
April 28, 2025
Since May 14, 2004, the Foundation has dedicated itself to supporting patients, advancing research, and advocating for early diagnosis and treatment of IgAN. WALL TOWNSHIP, NJ, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- The IgA Nephropathy …
Volatus Announces $2,000,000 Financing
GlobeNewswire
·
April 28, 2025
Not for distribution to United States newswire services or for dissemination in the United States. TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV:FLT) (OTCQX:TAKOF) (Frankfurt: ABB) (“Volatus” or the “Company”) is pleased to …
Cellectis présente une approche non virale d’édition du génome et des innovations avec les base editors à l’ASGCT 2025
GlobeNewswire
·
April 28, 2025
NEW YORK, 28 avr. 2025 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS - NASDAQ : CLLS) (la "Société"), société de biotechnologie de stade clinique, qui utilise sa technologie pionnière d'édition de génome pour développer des thérapies cellulaires …
Tevogen Reaffirms Oncology Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion
GlobeNewswire
·
April 28, 2025
Reflects business philosophy of commercial success through patient accessibility Recently executed agreement with CD 8 Technology Services LLC providing up to $50 million for Company’s dedicated R&D and manufacturing facility; no impact on shareholder …
Artiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting
GlobeNewswire
·
April 28, 2025
Prolonged duration of response, deep B-cell depletion, and well-tolerated safety profile support the potential of AlloNK® + rituximab for the treatment of B-cell driven diseases in a community setting Additional poster presentation to feature scalability …
Editas Medicine to Present Preclinical Data Demonstrating Progress in the Development of an in vivo Gene Editing Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
GlobeNewswire
·
April 28, 2025
CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company, today announced that five abstracts have been accepted for presentation, including one oral presentation, at the 28th Annual …
Trident Filed 2024 Annual Report on Form 20-F
GlobeNewswire
·
April 28, 2025
SINGAPORE, April 29, 2025 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd (“Trident” or the “Company,” NASDAQ: TDTH), a leading catalyst for digital transformation in technology optimization services and Web 3.0 activation based in Singapore, today …